Patient Retention In Clinical Trials And Recruitment Support

Patient Recruitment, Enrollment, and Retention Solutions

With dropout rates averaging 30%, delays caused by recruitment and retention challenges in patient retention in clinical trials can cost sponsors $600,000 to $8 million daily in lost future sales. Additionally, 70% of patients live more than an hour away from a study site, creating barriers to trial participation, limiting patient engagement, and increasing overall dropout rates.

20/20 Onsite has been shown to reduce patient travel by 80% and reduce patient dropout rates by 70% compared to the industry standard. Our industry-leading, patient-centric, point-of-need approach maintains budgets and timelines while fast-tracking trials.

• 91% Patient Retention Rate vs Industry Average of 70%
• 98% Data Accuracy Submission
• 85,000+ Point-of-need Eye Exams Performed

A Proven Approach to Patient-Centric Trial Success

At 20/20 Onsite, we bring ophthalmic assessments directly to patients, reducing the average travel distance by over 80%. This point-of-need approach enhances participant engagement, improves retention across diverse patient populations, reduces patient burden, and ensures clinical research trials stay on track through stronger, real-world retention strategies and more accessible outreach to potential participants.

• Enhanced Retention Rates: Proprietary data from 20/20 Onsite-supported trials indicate dropout rates of approximately 9%, compared to the industry standard of 30%.*
• Streamlined Assessments: Point-of-need services ensure high-quality data collection and support consistent study visits and trial management, maintaining data integrity without delays for clinical research teams.

Proven Results in Clinical Trials

• Dropout rates of 9% in trials where we provided point-of-need services.*
• 98% data submission accuracy ensures high-quality trial outcomes.
• 95+ patient NPS score due to our patient-centric solutions.

Streamlined Process Designed for Trial Success

1. Tailored Strategies to Fit Trial Needs

20/20 Onsite handles all logistics for our point-of-need clinics, including travel to study sites, setup, teardown, and data submission. We also provide real-time support during assessments, helping site staff, research coordinators, and other stakeholders involved in research studies. This streamlined approach improves clinical trial participation, supports smoother site visits, and strengthens overall participant retention.

2. Mobile Vision Clinics and On-site Pods for Seamless Patient Assessments

Our Mobile Vision Clinics travel directly to patients, reducing average travel from 67 miles to 12 and improving overall healthcare access. On-site pods provide a stationary alternative, offering flexible, high-quality assessments that support research participation and accommodate evolving study design needs.

3. Expert Staff and State-of-the-art Equipment Ensure Reliable Data

Our certified professionals ensure high-quality assessments that integrate seamlessly with your current protocols and study design to manage ophthalmic needs. This supports reliable data collection, consistent results across research studies, and smoother collaboration with site staff, providers, and research teams.

4. End-to-End Operational Support

We handle logistics, scheduling, and documentation, so you can focus on research. Our team works closely with site staff, research coordinators, and other stakeholders to address challenges, maintain smooth site visits, and ensure trials stay on track and on budget, supporting stronger participant recruitment, retention, and overall research participation.

5. High-Quality Data Collection and Reporting

With 98% data accuracy, we deliver reliable results that meet regulatory standards and accelerate trial progression.

Why It Works

20/20 Onsite combines convenience, expertise, and technology to improve recruitment, retention, and data accuracy—driving successful, patient-centric trials.

From reducing patient travel distances to less than 12 miles (on average) to achieving dropout rates as low as 9%, our methodology delivers measurable results that accelerate trial timelines and potentially reduce costs.